1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
(
- Contribution to journal › Letter
- 2020
-
Mark
Letter to the editor : Indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: A randomized controlled cross-over study
(
- Contribution to journal › Article
- 2019
-
Mark
Effects of baseline symptom burden on treatment response in COPD
(
- Contribution to journal › Article
-
Mark
Research highlights from the 2018 European Respiratory Society International Congress : airway disease
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations : A randomized controlled study
(
- Contribution to journal › Article
- 2016
-
Mark
Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies
(
- Contribution to journal › Article
- 2015
-
Mark
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life.
(
- Contribution to journal › Article
- 2014
-
Mark
Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD.
(
- Contribution to journal › Article
- 2013
-
Mark
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
(
- Contribution to journal › Article